UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055473
Receipt number R000063385
Scientific Title Risk Factors for Difficult Three-Port Laparoscopic Cholecystectomy
Date of disclosure of the study information 2024/09/10
Last modified on 2024/09/10 17:18:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Risk Factors for Difficult Three-Port Laparoscopic Cholecystectomy

Acronym

Risk Factors for Difficult Three-Port LC

Scientific Title

Risk Factors for Difficult Three-Port Laparoscopic Cholecystectomy

Scientific Title:Acronym

Risk Factors for Difficult Three-Port LC

Region

Japan


Condition

Condition

Cholecystitis, Cholecystolithiasis

Classification by specialty

Hepato-biliary-pancreatic surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Explore the factors that complicate reduced-port surgery

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Noncomplete LC which was defined as a change of 5-mm to 12-mm port, addition of ports, change to subtotal cholecystectomy, or open conversion cholecystectomy.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

Patients who underwent three-port LC using two 5-mm port and 12-mm umbilical port for symptomatic cholecystolithiasis, chronic cholecystitis, and acute cholecystitis between November 2021 and November 2023 by a single surgeon were retrospectively collected.

Key exclusion criteria

Patients with suspected gallbladder cancer

Target sample size

47


Research contact person

Name of lead principal investigator

1st name Goshi
Middle name
Last name Fujimoto

Organization

Koga Community Hospital

Division name

Department of Gastroenterological Surgery

Zip code

425-0088

Address

2-30-1 Daikakuji, Yaizu, Shizuoka 425-0088, Japan

TEL

09021690887

Email

g_chimera_7@yahoo.co.jp


Public contact

Name of contact person

1st name Goshi
Middle name
Last name Fujimoto

Organization

Koga Community Hospital

Division name

Gastroenterological surgery

Zip code

425-0088

Address

2-30-1 Daikakuji, Yaizu, Shizuoka 425-0088, Japan

TEL

09021690887

Homepage URL


Email

g_chimera_7@yahoo.co.jp


Sponsor or person

Institute

Koga Community Hospital

Institute

Department

Personal name

Goshi Fujimoto


Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Koga Community Hospital

Address

2-30-1 Daikakuji, Yaizu, Shizuoka 425-0088, Japan

Tel

09021690887

Email

g_chimera_7@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 09 Month 10 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled

47

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2024 Year 02 Month 15 Day

Date of IRB

2024 Year 02 Month 15 Day

Anticipated trial start date

2024 Year 02 Month 15 Day

Last follow-up date

2024 Year 10 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

retrospective cohort study


Management information

Registered date

2024 Year 09 Month 10 Day

Last modified on

2024 Year 09 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063385